MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer
暂无分享，去创建一个
Y. Carmi | A. Mock | J. Hess | P. Saintigny | B. Rotblat | M. Scaltriti | M. Elkabets | S. Jagadeeshan | I. Kurth | E. Voronov | I. Allon | L. Morris | T. Cooks | J. Fayette | Idan Cohen | Jonathan Zorea | M. Prasad | B. Joshua | A. Karabajakian | L. Cohen | Ksenia M. Yegodayev | J. Bouaoud | O. Novoplansky | L. Michon | Orr Dimitstein | De-xiao Kong | Cristina Conde-López | Ksenia M Yegodayev | A. B. Shnerb | Sooraj Mathukkada | Mai Badarni | Sapir Tzadok | L. Brezina | Ofra Novoplansky | Idan Cohen | Limor Cohen | Tomer Cooks | Yaron Carmi | Cristina Conde-Lopez